Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 07/25 11:54:33 am
1660 GBp   +0.03%
07/22GLAXOSMITHKLINE : half-yearly earnings release
07/20DJBrexit Fears and Weak Pound Weigh on Corporate Europe
07/19 APPLE : GlaxoSmithKline partner for arthritis study
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline Buys Back 1.3 Million Shares

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/04/2012 | 06:28pm CEST

GlaxoSmithKline PLC (>> GlaxoSmithKline plc) said Friday it has purchased 1,300,000 ordinary shares to be held in treasury.

MAIN FACTS:

-Highest price paid: 1455 pence per share.

-Lowest price paid: 1425 pence per share.

-Shares at 1610 GMT down 1%, at 1427 pence, valuing the company at GBP72 billion.

-By Mark Shapland, Dow Jones Newswires; +44 207 8429358; mark.shapland@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc, GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
07/22 GLAXOSMITHKLINE PAKISTAN : Loss of Shares of GlaxoSmithKline Pakistan Limited
07/22GLAXOSMITHKLINE PLC : half-yearly earnings release
07/20DJBrexit Fears and Weak Pound Weigh on Corporate Europe
07/19 APPLE : GlaxoSmithKline partner for arthritis study
07/18 GLAXOSMITHKLINE : Glaxo's ViiV Sees Positive Results In Phase IIIb Triumeq Study
07/18 GLAXOSMITHKLINE : Glaxo Gets China Approval For Cervarix Cervical Cancer Vaccine
07/18DJGLAXOSMITHKLINE : China's Food and Drug Administration Approves GlaxoSmithKline'..
07/14 GLAXOSMITHKLINE : *exane bnp raises glaxosmithkline price target to 1530 pence -..
07/14 GLAXOSMITHKLINE : *jefferies raises glaxosmithkline to 'buy' (hold) - price targ..
07/13DJBusiness Watch -- WSJ
More news
Sector news : Pharmaceuticals - NEC
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJBAYER : 2Q 2016 -- Forecast
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBIOGEN : Announces CEO Search, Lifts Guidance--2nd Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07/24 WEEK IN REVIEW : Cross-Border Investments Rule The News
07/22 SetPoint Off To A Good Start In The Clinic
07/21 Big Pharma Dominates Healthcare But Caregivers Are Top Sector Yield Dogs In J..
07/20 A Much-Needed Long Awaited Game Changing Vaccine
07/20 Celgene Pays Through The Nose For A Hand In Immune Checkpoints
Advertisement
Financials ( GBP)
Sales 2016 26 340 M
EBIT 2016 6 684 M
Net income 2016 2 803 M
Debt 2016 12 843 M
Yield 2016 4,88%
P/E ratio 2016 32,29
P/E ratio 2017 23,56
EV / Sales 2016 3,56x
EV / Sales 2017 3,42x
Capitalization 80 857 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 27
Average target price 16,3  GBP
Spread / Average Target -1,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Andrew Philip Witty Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Moncef Slaoui Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC20.87%105 959
JOHNSON & JOHNSON21.72%343 913
PFIZER INC.13.82%222 823
NOVARTIS AG-5.13%219 526
ROCHE HOLDING LTD.-9.62%218 832
MERCK & CO., INC.11.36%162 815
More Results